ADIPOQ and type 2 diabetes mellitus: Higher adiponectin concentrations are associated with a reduced risk of T2D in BA subjects [33, 34], which is thought to be mediated via adiponectin’s beneficial effects on both insulin sensitivity [34] and beta-cell proliferation and survival.